Abiraterone for "STAMPEDE-Like" cohort of high-risk prostate cancer in the PSMA-PET era: too much, too early? [PDF]
Murthy V +7 more
europepmc +1 more source
Plain language review: the safety of relugolix combination therapy for advanced prostate cancer. [PDF]
La Cerda J +6 more
europepmc +1 more source
Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort. [PDF]
Wenzel M +12 more
europepmc +1 more source
Differences in verbal memory, visuospatial ability and cognitive inhibition among young women using drospirenone and ethinyl oestradiol oral contraceptives versus naturally cycling controls. [PDF]
Lagunas N +4 more
europepmc +1 more source
Comparison of Substances in Combined Oral Contraceptives Used in Acne Vulgaris, Hirsutism, Migraine, and Dysmenorrhea. [PDF]
Wójcikiewicz P +4 more
europepmc +1 more source
Corticosteroid Use and Risk of Adverse Events in Metastatic Hormone-Sensitive Prostate Cancer. [PDF]
Swami U +8 more
europepmc +1 more source
Stabilization of Abiraterone in Human Plasma Using the Esterase Inhibitor Bis(4-nitrophenyl) Phosphate. [PDF]
Bruin MAC +4 more
europepmc +1 more source
Safety and Efficacy of a 24-Cycle Administration of a Drospirenone-Only Pill in Japanese Women. [PDF]
Kitamura K +5 more
europepmc +1 more source
Diaphragmatic endometriosis associated with pelvic endometriosis: a case report. [PDF]
de Matos RTM +5 more
europepmc +1 more source
Acute Kidney Injury in a Cancer Patient Exposed to Relugolix and Abiraterone.
Elleisy M +4 more
europepmc +1 more source

